Bonaduz, Switzerland (08.01.2018) – Hamilton has developed a method for automating the library preparation of SOPHiA GENETICS’ CE-IVD marked HCS application in an advanced and flexible way.
The HCS by SOPHiA GENETICS is the first capture-based application that detects all types of genomic variants (e.g. SNVs, Indels & CNVs) in 26 genes associated with breast, ovarian and digestive cancers. Based on a standardized process, it assures clinical-grade analytical performance. The automated workflow on Microlab® STARlet™
reduces the bias associated with manual sample preparation further standardizing the process and minimizing human intervention.
During the validation study of the automated solution, performed at the Clinical Genomics Laboratory of Modena University Hospital in Italy, excellent results were obtained by identifying all confirmed variants.
The Microlab® STARlet™, equipped with proven Hamilton technology like CO-RE, MAD, and cLLD, combined with the HCS by SOPHiA GENETICS, provides a high degree of robustness and process-safety, that is a must for routine diagnostics.
Hamilton Robotics, an affiliate of the Hamilton Company, is a leading global manufacturer and provider of automated liquid handling workstations and laboratory automation technology to the scientific community. With a focus on innovative design, Hamilton products incorporate patented liquid handling technologies into a portfolio that includes liquid handling platforms, standard application-based solutions, small devices, consumables, and OEM liquid handling solutions. Known for advancing life science, clinical diagnostics, forensics and biotechnology industries, Hamilton products offer reliability, performance and flexibility. Ensuring a continuous commitment to quality, Hamilton utilizes state-of-the-art manufacturing at production facilities in Reno, Nevada and Bonaduz, Switzerland, and has earned a global ISO 9001 certification. Privately held, Hamilton maintains headquarters in Reno, Nevada; Franklin, Massachusetts; Bonaduz, Switzerland, along with subsidiary offices throughout the world. www.hamiltoncompany.com/robotics
About SOPHiA GENETICS
Global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA™ AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. The global network of 385 institutions from 55 countries that use the SOPHiA DDM® analytical platform powered by SOPHiA form the world’s largest clinical genomics community. By enabling the rapid adoption of genomic testing worldwide, turning data into actionable clinical insights, and sharing knowledge through its community, SOPHiA GENETICS is democratizing Data-Driven Medicine to save lives. More info: http://www.sophiagenetics.com